Law and research could add up to profitable niche drugs
- PMID: 17443162
- DOI: 10.1038/446856b
Law and research could add up to profitable niche drugs
Comment on
-
A changing drug supply.Nature. 2007 Feb 1;445(7127):460. doi: 10.1038/445460a. Nature. 2007. PMID: 17268432 No abstract available.
-
Niche drugs aren't a cheap alternative to blockbusters.Nature. 2007 Feb 22;445(7130):818. doi: 10.1038/445818c. Nature. 2007. PMID: 17314952 No abstract available.
Similar articles
-
Regulators adopt more orphan drugs.Nature. 2014 Apr 3;508(7494):16-7. doi: 10.1038/508016a. Nature. 2014. PMID: 24695293 No abstract available.
-
Rare diseases, orphan drugs, and orphaned patients.Mol Interv. 2006 Aug;6(4):186-91. doi: 10.1124/mi.6.4.2. Mol Interv. 2006. PMID: 16960139 No abstract available.
-
Lucrative niches: how drugs for rare diseases became lifeline for companies.Wall St J (East Ed). 2005 Nov 15:A1, A18. Wall St J (East Ed). 2005. PMID: 16502531 No abstract available.
-
The impact of the Orphan Drug Act on the development and advancement of neurological products for rare diseases: a descriptive review.Clin Pharmacol Ther. 2010 Oct;88(4):449-53. doi: 10.1038/clpt.2010.193. Clin Pharmacol Ther. 2010. PMID: 20856241 Review.
-
Rare diseases, orphan drugs and their regulation: questions and misconceptions.Nat Rev Drug Discov. 2010 Dec;9(12):921-9. doi: 10.1038/nrd3275. Epub 2010 Nov 9. Nat Rev Drug Discov. 2010. PMID: 21060315 Review.
Cited by
-
The ethics of psychopharmacological research in legal minors.Child Adolesc Psychiatry Ment Health. 2008 Dec 8;2(1):39. doi: 10.1186/1753-2000-2-39. Child Adolesc Psychiatry Ment Health. 2008. PMID: 19063724 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources